Delayed Diagnostic Time& Inflammatory Bowel Diseased Patients
NCT ID: NCT04952558
Last Updated: 2021-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
700 participants
OBSERVATIONAL
2021-07-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Estimate time delay for diagnosis of Egyptian inflammatory bowel diseased patients
2. compare the delay time for diagnosis of Egyptian inflammatory bowel diseased patients globally
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Biomarkers in Inflammatory Bowel Disease
NCT03833310
Biological Therapy in Patients With Inflammatory Bowel Disease
NCT05599867
Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
NCT05002166
Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients
NCT05720221
Vitamin D Status in Inflammatory Bowel Disease
NCT03496246
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Introduction The incidence of inflammatory bowel disease \[IBD\] is increasing worldwide. Both Crohn's disease \[CD\] and ulcerative colitis \[UC\] are therefore becoming an important public health issue\[1\] The IBD is characterized by chronic intestinal inflammation, which can cause bowel damage and intestinal complications primarily depending on the duration and severity of the inflammation\[2\] The diagnosis of inflammatory bowel diseases (IBD) is often established following considerable delay due to nonspecific and inconsistent symptoms. In previous western studies, the delayed diagnosis was associated with poor outcome in patients with Crohn's disease (CD).\[2\] Timely diagnosis is not only important for the patients themselves but has also become a relevant public health issue due to the rising incidence of IBD worldwide\[3\] Abdominal pain is the most prevalent initial chief complaint in patients with CD; however, it is also a common symptom of other digestive disorders, such as irritable bowel syndrome may the pain is not severe, it is easily regarded as trivial, and the diagnosis may be missed because the tests needed for the diagnosis of IBD are not performed. \[4\] A delayed diagnosis of CD may incur high medical cost in patients who develop aggressive disease that requires treatment with anti-TNFα agents\[5\] Aim of the study
1. Estimate time delay for diagnosis of Egyptian inflammatory bowel diseased patients
2. compare the delay time for diagnosis of Egyptian inflammatory bowel diseased patients globally
3. studing risk factors that causing diagnostic delay among Egyptian inflammatory bowel diseased patients the time
4. frequency of diagnosed complicated inflammatory bowel diseased as first time presentation
Patients and methods Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions
Inclusion criteria Egyptian inflammatory bowel diseased patients above the age of 18 years with definite diagnosis based on clinical ,endoscopic ,histological basis
Detailed history will be taken from all included patients focus on
* age ,sex , special habit ,residence .
* education level -socioeconomic status
* type of the inflammatory bowel disease
* lag time for reaching the proper diagnosis of inflammatory bowel disease which definite as time from the first symptoms presentation to reaching definite diagnosis
* symptoms that causing patients seeking medical advice
* number of Inflammatory bowel diseased patients referred for first time from surgeons
* number of patients have perianal symptoms
* number of patients have previous history of appendicectomy
* physicians numbers that visited by the patients to reaching the diagnosis
* ileal intubation at first time colonoscopy
* number of patients change their diagnosis from ulcerative colitis to Crohn's disease
* type of radiological assessment of the examined patients
Exclusion criteria Inflammatory bowel diseased Patients below 18 years old
Ethical consideration:
consent will be taken from all participating patients and must be approved by the ethical committee
References :
1. E. V. Loftus, "Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences," Gastroenterology, vol. 126, no. 6, pp. 1504-1517, 2004, doi: 10.1053/j.gastro.2004.01.063.
2. D. W. Lee et al., "Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery," World J. Gastroenterol., vol. 23, no. 35, pp. 6474-6481, Sep. 2017, doi: 10.3748/wjg.v23.i35.6474.
3. S. R. Vavricka et al., "Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease," Inflamm. Bowel Dis., vol. 18, no. 3, pp. 496-505, Mar. 2012, doi: 10.1002/ibd.21719.
4. G. Novacek et al., "Diagnostic delay in patients with inflammatory bowel disease in Austria," Wien. Klin. Wochenschr., vol. 131, no. 5-6, pp. 104-112, Mar. 2019, doi: 10.1007/s00508-019-1451-3.
5. L. Cantoro et al., "The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study," J. Crohn's Colitis, vol. 11, no. 8, pp. 975-980, Aug. 2017, doi: 10.1093/ecco-jcc/jjx041.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cross sectional observational study
Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions
Detailed history will be taken from all included patients focus on
* age ,sex , special habit ,residence .
* education level -socioeconomic status
* type of the inflammatory bowel disease
* lag time for reaching the proper diagnosis of inflammatory bowel disease which definite as time from the first symptoms presentation to reaching definite diagnosis
* symptoms that causing patients seeking medical advice
* number of Inflammatory bowel diseased patients referred for first time from surgeons
* number of patients have perianal symptoms
* number of patients have previous history of appendicectomy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bahaa osman taha
assistant lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bahaa Osman Taha
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESIBD1989BAHAA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.